A SBIR Phase I contract was awarded to Reaction Biology Corporation in May, 2015 for $290,439.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Reaction Biology Corporation in July, 2015 for $222,902.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Reaction Biology Corporation in April, 2016 for $247,791.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Reaction Biology Corporation in April, 2016 for $1,461,580.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Reaction Biology Corporation in February, 2017 for $1,561,844.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Reaction Biology Corporation for $100,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Reaction Biology Corporation for $750,869.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Reaction Biology Corporation for $100,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Reaction Biology Corporation for $100,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Reaction Biology Corporation for $170,727.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Reaction Biology Corporation for $287,650.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Reaction Biology Corporation for $1,402,563.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Reaction Biology Corporation for $947,589.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Reaction Biology Corporation for $100,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Reaction Biology Corporation for $1,203,230.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Reaction Biology Corporation for $463,506.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Reaction Biology Corporation for $252,860.0 USD from the U.S. Department of Health & Human Services.